Metronidazole in Dobermans: A Call for Cautious Use
Metronidazole, while still a viable option for certain medical conditions (e.g., Giardia, albeit not the first-line choice as Robertson (2021) states), has sparked considerable debate due to its side effects and impact on gut health. Moreover, newer research on its effect on acute diarrhea suggests that metronidazole may be no better than a placebo (Shmalberg et al., 2019). As Dr. Brennan McKenzie pointed out in an interview, Metronidazole has been overprescribed for idiopathic (without known origin) diarrhea, much due to anecdotal evidence rather than reliance on newer research (Veterinary Information Network, 2023). Understanding the full scope of these issues is crucial for advocating for responsible medication management and safeguarding the well-being of our Dobermans.
The Intricacies of Metronidazole
Metronidazole, originally developed for human use, has entered veterinary medicine due to its proposed effectiveness against certain pathogens, but has sparked considerable debate about its risks in both human and animal applications. In veterinary medicine, metronidazole is not approved by the FDA (Mercer & Canevale, 2022). Instead, it’s used off-label (Mercer & Canevale, 2022). While this situation is not uncommon, newer research (Shmalberg et al., 2019; Langlois et al., 2020) raises questions about its efficacy in acute, idiopathic diarrhea cases.
Note: Metronidazole is not approved for veterinary use in animals used for food generation due to its suggested carcinogenic effects found when given to mice over prolonged periods (Mercer & Canevale, 2022). Furthermore, metronidazole should be avoided in pregnant animals (Mercer & Canevale, 2022).
Indifferent Mechanism of Action
Metronidazole operates by attacking the DNA of bacteria and protozoa (Pfizer, 2024), effectively halting their replication process (Sigeti et al., 1983). While this mechanism may be advantageous for treating infections caused by some of these organisms, the issue is that Pilla et al. (2020) showed that in healthy dogs, metronidazole significantly changed microbiome composition, caused decreases in richness, significantly decreased Fusobacteria, Clostridium hiranonis, and significantly increased the fecal dysbiosis index. This activity is where the root of the gut flora issue, discussed subsequently, lies.
Metronidazole and Acute Diarrhea: Why Routine Use Deserves More Scrutiny
Metronidazole is still commonly prescribed for acute, idiopathic canine diarrhea, but the evidence does not appear to support treating it as an automatic first-line response, especially in uncomplicated cases. Shmalberg et al. (2019) found that dogs receiving metronidazole reached acceptable fecal consistency in 4.6 ± 2.4 days, compared with 4.8 ± 2.9 days in the placebo group, and that difference was not statistically significant. Langlois et al. (2020) did find a statistically significant decrease of about 1.5 days in diarrhea duration with metronidazole versus placebo, but the same paper also stressed that most dogs improved within several days regardless of treatment. Taken together, the studies suggest that metronidazole’s benefit in uncomplicated acute diarrhea is, at best, inconsistent rather than reliably decisive.
Gut Flora: The Cornerstone of Canine Health
What is much less ambiguous is metronidazole’s impact on the gut microbiome. Igarashi et al. (2014) showed that metronidazole significantly decreased bacterial diversity and significantly altered bacterial composition by day 14 in healthy dogs. Pilla et al. (2020) then showed that metronidazole significantly increased the fecal dysbiosis index, decreased key bacteria, including Clostridium hiranonis, and in 7 of 16 dogs, some microbiome and bile-acid changes had not fully resolved four weeks after discontinuation. Given these findings, while the clinical upside in uncomplicated diarrhea is mixed, the microbiome downside is not speculative.
The probiotic literature does not prove that every probiotic product is interchangeable or universally superior to metronidazole, because the studies used different strains and products. However, the data do show that non-antibiotic approaches can perform at least as well, and sometimes better, in acute uncomplicated diarrhea. Herstad et al. (2010) found that the probiotic group had a shorter time to last abnormal stool than the placebo group, with means of 1.3 days versus 2.2 days. Kelley et al. (2009) reported that dogs receiving canine-derived Bifidobacterium animalis AHC7 had faster diarrhea resolution than placebo-treated dogs, at 3.9 ± 2.3 days versus 6.6 ± 2.7 days. Nixon et al. (2019) reported that the anti-diarrheal probiotic paste group had better clinical outcomes than placebo in dogs with acute uncomplicated diarrhea. And in Shmalberg et al. (2019), the probiotic group again had the shortest mean time to acceptable fecal consistency at 3.5 ± 2.2 days, compared with 4.6 ± 2.4 days for metronidazole and 4.8 ± 2.9 days for placebo, even though those differences were not statistically significant.
Current Guidelines & Reasoning
Current guideline-level recommendations reflect these findings. The 2024 ENOVAT guidelines recommend against antimicrobials in dogs with mild acute non-hemorrhagic diarrhea, mild acute hemorrhagic diarrhea, and moderate acute diarrhea, and reserve antimicrobial treatment for severe disease or clear exceptions (Jessen et al., 2024).
Taken together, while it would be an overstatement to say that metronidazole is never useful, routine metronidazole use for uncomplicated acute, idopathic diarrhea is weakly supported, often unnecessary, and difficult to justify as a default when the condition is frequently self-limiting, and the drug’s microbiome effects are well documented. It is, therefore, prudent to discuss metronidazole use with your veterinarian and inquire about the reasoning behind prescribing the medication in your dog’s case.
Good to Know About Metronidazole
Side-Effects
While metronidazole can be an effective (part of) treatment for Giardia (Jones et al, 2025; Ciuca et al., 2021), potential side effects should be considered individually and in context.
Neurological effects: In four-month-old puppies, dose-dependent symptoms ranged from mild (twitching, head tilting) to severe (ataxia or loss of coordination, and stiffness) (Virbac AH, Inc., 2023). Tremors and seizures (Sawar & Bey, 2025).
Digestive issues: Although prescribed for diarrhea, metronidazole can cause gastrointestinal upset, including vomiting, loss of appetite, and further diarrhea (Virbac AH, Inc., 2023).
Liver impact: Metronidazole can be hard on the liver, an organ crucial to processing drugs and toxins. Caution is warranted in dogs with hepatic dysfunction (Virbac AH, Inc., 2023). In Dobermans, this can be of particular concern due to their predisposition to liver problems (Gough et al., 2018). Monitoring liver function through blood tests before and during treatment can be advisable to prevent complications, depending on the dog’s context.
Specific Concerns for Puppies and Young Dogs
In younger canines, particularly puppies and adolescents, the risks associated with metronidazole may be even more pronounced. Their liver is still developing (Fuchs et al., 2024), making them possibly more susceptible to the drug's side effects. In a veterinary pediatric pharmacology chapter, the author states that in neonatal puppies, hepatic drug metabolism is reduced, both phase I and phase II reactions are diminished, and some phase I activity may not reach adult levels until about 135 days postpartum (Boothe, 2016). As such, it could also be reasonable to infer that puppies may still have a reduced ability to process drugs, which may make them more susceptible to a higher risk of toxicity. Additionally, their developing nervous systems can be more vulnerable to neurological effects, due to, but not limited to, an immature blood-brain barrier, which means that drugs can gain easier access to the CNS, and that this creates a greater potential for toxicity (Fitzgerald & Newquist, 2011). This can be particularly crucial for breeds like Dobermans, where such risks can exacerbate breed-specific health concerns.
Moreover, puppies are in the critical stage of developing their gut flora. Guard et al. (2017), showed clear shifts in the fecal microbiota of puppies from day 2 to day 56 after birth, with the puppy microbiome at 8 weeks still significantly different from that of the mothers. The use of metronidazole, as shown, affects dogs’ gut flora (Igarashi et al. 2014; Pilla et al., 2020). A 2023 companion-animal review found that antimicrobials profoundly disrupt the GI microbiota, that early-life exposure may increase susceptibility to disease, and that the strongest long-term evidence comes from human and experimental-animal work, while dog and cat long-term data remain limited (Stavroulaki et al., 2023). Given metronidazole's effect on the gut flora and the fact that puppies have still developing livers and neurological systems, it appears prudent to discuss and weigh the potential (long-term) effects of metronidazole in puppies against the benefits in each individual case.
Advocating for Responsible Prescription
Given these concerns, it is imperative for veterinarians and Doberman owners to work together to ensure metronidazole is only used when absolutely necessary and appropriate. This may include:
Accurate Diagnosis: Confirm with your veterinarian that the dog's condition is indeed caused by bacteria or protozoa that respond to metronidazole. Giardiasis, even if not, unlike Fenbendazole, the first-line medication (Robertson, 2021), is likely and appropriately treated with Metronidazole. However, even though true drug resistance is difficult to determine in dogs, resistance has become an area of interest and scrutiny increasingly as well (Smith & Starkey, 2025). Thus, push for an accurate diagnosis and ask your veterinarian questions even if Giardiasis is your Doberman’s diagnosis.
Dose Appropriateness: Have the veterinarian tailor the dose and duration to the specific dog, considering breed sensitivities and individual health history.
Monitoring and Management: Regularly monitor the dog's response to the medication and adjust treatment with your veterinarian as necessary.
Empowering Informed Decisions
By understanding the complex nature of metronidazole, its effects on gut flora, and potential side effects, Doberman owners and vets can make more informed decisions about its use. While it likely remains a viable medication for certain conditions, its prescription should never be taken lightly, especially in dogs known to be sensitive. Through cautious and informed use, we can help ensure the health and well-being of our beloved Dobermans, avoiding unnecessary complications and fostering a healthier, happier life.
References
Boothe, D. M. (2016, September 10). Factors affecting drug disposition. Veterian Key. https://veteriankey.com/factors-affecting-drug-disposition/
Ciuca, L., Pepe, P., Bosco, A., Caccio, S. M., Maurelli, M. P., Sannella, A. R., Vismarra, A., Cringoli, G., Kramer, L., Rinaldi, L., & Genchi, M. (2021). Effectiveness of fenbendazole and metronidazole against Giardia infection in dogs monitored for 50-days in home-conditions. Frontiers in Veterinary Science, 8, 626424. https://doi.org/10.3389/fvets.2021.626424
Fitzgerald, K. T., & Newquist, K. L. (2011). Husbandry of the Neonate. Small Animal Pediatrics, 44–52. https://doi.org/10.1016/B978-1-4160-4889-3.00006-1
Fuchs, K. D. M., Pereira, K. H. N. P., Xavier, G. M., Mendonça, J. C., Barreto, R. O., Silva, R. C., de Souza, F. F., & Lourenço, M. L. G. (2024). Neonatal hypoglycemia in dogs-pathophysiology, risk factors, diagnosis and treatment. Frontiers in Veterinary Science, 11, 1345933. https://doi.org/10.3389/fvets.2024.1345933
Gough, A., Thomas, A., & O’Neill, D. Breed predispositions to disease in dogs and cats. Wiley Blackwell.
Guard, B. C., Mila, H., Steiner, J. M., Mariani, C., Suchodolski, J. S., & Chastant-Maillard, S. (2017). Characterization of the fecal microbiome during neonatal and early pediatric development in puppies. PloS one, 12(4), e0175718. https://doi.org/10.1371/journal.pone.0175718
Herstad, H. K., Nesheim, B. B., L'Abée-Lund, T., Larsen, S., & Skancke, E. (2010). Effects of a probiotic intervention in acute canine gastroenteritis--a controlled clinical trial. The Journal of Small Animal Practice, 51(1), 34–38. https://doi.org/10.1111/j.1748-5827.2009.00853.x
Igarashi, H., Maeda, S., Ohno, K., Horigome, A., Odamaki, T., & Tsujimoto, H. (2014). Effect of oral administration of metronidazole or prednisolone on fecal microbiota in dogs. PloS One, 9(9), e107909. https://doi.org/10.1371/journal.pone.0107909
Jessen, L. R., Werner, M., Singleton, D., Prior, C., Foroutan, F., Ferran, A. A., Arenas, C., Bjørnvad, C. R., Lavy, E., Allerton, F., Allensbach, K., Guardabassi, L., Unterer, S., Bodnárová, T., Windahl, U., Brennan, M. L., Weese, J. S., & Scahill, K. (2024). European Network for Optimization of Veterinary Antimicrobial Therapy (ENOVAT) guidelines for antimicrobial use in canine acute diarrhoea. The Veterinary Journal, 307, 106208. https://doi.org/10.1016/j.tvjl.2024.106208
Jones, S., Briantais, P., Von Simson, C., De Meyrignac, E., Poincelot, L., & Rigaut, D. (2025). Treatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspension. Parasites & vectors, 18(1), 169. https://doi.org/10.1186/s13071-025-06797-wv
Kelley, R. L., Minikhiem, D., Kiely, B., O'Mahony, L., O'Sullivan, D., Boileau, T., & Park, J. S. (2009). Clinical benefits of probiotic canine-derived Bifidobacterium animalis strain AHC7 in dogs with acute idiopathic diarrhea. Veterinary therapeutics: Research in Applied Veterinary Medicine, 10(3), 121–130. https://www.zora.uzh.ch/server/api/core/bitstreams/359951ea-7b96-44ab-9a9f-cf8e2d3fc440/content
Langlois, D. K., Koenigshof, A. M., & Mani, R. (2020). Metronidazole treatment of acute diarrhea in dogs: A randomized double blinded placebo-controlled clinical trial. Journal of Veterinary Internal Medicine, 34(1), 98–104. https://doi.org/10.1111/jvim.15664
Nixon, S. L., Rose, L., & Muller, A. T. (2019). Efficacy of an orally administered anti-diarrheal probiotic paste (Pro-Kolin Advanced) in dogs with acute diarrhea: A randomized, placebo-controlled, double-blinded clinical study. Journal of Veterinary Internal Medicine, 33(3), 1286–1294. https://doi.org/10.1111/jvim.15481
Mercer, M.A., & Carnevale, J. (2022). Nitroimidazoles Use in Animals. https://www.merckvetmanual.com/pharmacology/antibacterial-agents/nitroimidazoles-use-in-animals
Pfizer. (2024, July). FLAGYL®(metronidazole) tablets. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/012623s072lbl.pdf
Pilla, R., Gaschen, F. P., Barr, J. W., Olson, E., Honneffer, J., Guard, B. C., Blake, A. B., Villanueva, D., Khattab, M. R., AlShawaqfeh, M. K., Lidbury, J. A., Steiner, J. M., & Suchodolski, J. S. (2020). Effects of metronidazole on the fecal microbiome and metabolome in healthy dogs. Journal of Veterinary Internal Medicine, 34(5), 1853–1866. https://doi.org/10.1111/jvim.15871
Robertson, L.J. (2021). Giardiasis in animals. https://www.merckvetmanual.com/digestive-system/giardiasis-giardia/giardiasis-in-animals
Sawar, J. & Bey, G. (2025, April 21). Metronidazole for dogs: A common antibiotic to treat diarrhea and infections. https://www.goodrx.com/pet-health/dog/metronidazole-for-dogs
Shmalberg, J., Montalbano, C., Morelli, G., & Buckley, G. J. (2019). A randomized double blinded placebo-controlled clinical trial of a probiotic or metronidazole for acute canine diarrhea. Frontiers in Veterinary Science, 6, 163. https://doi.org/10.3389/fvets.2019.00163
Sigeti, J. S., Guiney, D. G., Jr, & Davis, C. E. (1983). Mechanism of action of metronidazole on Bacteroides fragilis. The Journal of Infectious Diseases, 148(6), 1083–1089. https://doi.org/10.1093/infdis/148.6.1083
Smith, R. C., & Starkey, L. A. (2025, January). Update on giardiasis: Diagnostics, treatment, and management. Today's Veterinary Practice. https://todaysveterinarypractice.com/parasitology/update-on-giardiasis-diagnostics-treatment-and-management/
Stavroulaki, E. M., Suchodolski, J. S., & Xenoulis, P. G. (2023). Effects of antimicrobials on the gastrointestinal microbiota of dogs and cats. Veterinary journal (London, England : 1997), 291, 105929. https://doi.org/10.1016/j.tvjl.2022.105929
Veterinary Information Network. (2023, April 3). Veterinarian lauded for his skepticism. https://news.vin.com/apputil/project/defaultadv1.aspx?id=11450205
Virbac AH, Inc. (2023, October 26). AYRADIA- metronidazole solution [Package insert]. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc79a63f-e3a3-4781-9c8f-7a128310fa6c
Disclaimer: The information provided in this article is for educational and informational purposes only and is not intended as a substitute for advice from your veterinarian or other healthcare professional. You should not use this information to diagnose or treat a health problem or disease or prescribe any medication or other treatment. Always consult with your veterinarian or other qualified healthcare provider before making any changes to your pet's healthcare regimen, especially if they have or suspect they may have a health problem. The author and publisher of this article are not responsible for any adverse effects or consequences resulting from the use of any suggestions, products, or procedures mentioned in this article. The use of this information is at the reader's discretion and risk.
Article last updated: April 2026
